November 4th 2024
Application acceptance was based on positive results with monthly and bi-monthly dosing data from a phase 3 trial.
September 13th 2024
Shaping the Management of COPD with Biologic Therapy
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Patient, Provider & Caregiver Connection™: Understanding the Patient Journey to Provide Personalized Care for Generalized Pustular Psoriasis
View More
Children with cow’s milk allergies smaller, lighter than peers with nut allergies
July 3rd 2020A retrospective study reveals that children with cow’s milk allergies—and the restrictive diets they must follow—may negatively impact their growth and development in comparison to their peers with other food allergies.
How treating food allergies and AD has changed
September 27th 2019Food allergies are a hot topic on the playground, at schools, and in pediatric offices. Parents of children with eczema or atopic dermatitis (AD) often have a lot of questions regarding the connection between eczema, exposure to common food allergens, and the development of or exacerbation of AD. There are many of the complex questions that clinicians must answer when evaluating pediatric patients with AD.
Rethinking how anaphylaxis presents
August 28th 2019Dr. Todd A. Mahr, president of the American College of Allergy, Asthma, and Immunology, discusses anaphylaxis and when to have your patient seek specialty care. Anaphylaxis is typically thought of as severe, acute and visibly evident. However, as Dr. Mahr points out, anaphylaxis can present differently in infants and young children.
Epinephrine autoinjectors for anaphylaxis
August 9th 2019Epinephrine is essential for treating anaphylaxis in children, and autoinjectors are the preferred method for administering epinephrine in an anaphylactic emergency. There is no one-size-fits-all approach to the optimal dose for all children, so here is expert advice about how to choose what’s best for your patient.
Antibiotics or antacids in infancy may increase risk of allergy
June 1st 2018Exposure to acid-suppressive medications or antibiotics in the first 6 months of life is associated with development of allergic disease, according to a retrospective study in more than 750,000 children from within 35 days of birth until aged at least 1 year.